Page 8 - MemoriaCIBER-2017ENG

Internal Organisation
The Consorcio Centro de Investigación Biomédica en Red, M P (CIBER), set up under the auspices of the Instituto de Salud Carlos III (ISCIII), fosters excellence research into Biomedicine and Health Sciences done in the National Health System and in the Science and Technology System
After the three new areas (CIBERCV, CIBERFES and CIBERONC) joined this in 2017, the scienti c pro- gramme of the CIBER is based on the following thematic research areas:
• Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) • Cardiovascular Diseases (CIBERCV)
• Diabetes and Metabolic Diseases(CIBERDEM)
• Liver and Digestive Diseases (CIBEREHD)
• Rare Diseases (CIBERER)
• Respiratory Diseases (CIBERES)
• Epidemiology and Public Health (CIBERESP)
• Frailty and Healthy Ageing (CIBERFES)
• Physiopathology of Obesity and Nutrition (CIBEROBN) • Cancer (CIBERONC)
• Mental Health (CIBERSAM)
At the present time the CIBER has a sta of 908 persons and around 6000 attached researchers, forming part of over 400 research groups, working in separate locations, associated with 104 institutions in the consortium and belonging to administrations and public and private sector institutions of Spain’s di er- ent “Autonomous Communities” or regional administrative areas
The governing, management and administrative bodies are as follows:
Governing Board and Permanent Commission
The Governing Board, presided over by the Director of the ISCIII, is made up of three representatives of the ISCIII and an institutional representative for each of the institutions in the consortium, appointed by the senior authority of these It meets every six months
The Permanent Commission is a delegated commission made up of the ISCIII and 8 members of the Governing Board, who can be renewed annually Both its operation and the support and assessment functions of the governing bodies are established in the statutes of the CIBER
8 CIBER ANNUAL REPORT 2017